1. Home
  2. MSEX vs IOVA Comparison

MSEX vs IOVA Comparison

Compare MSEX & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Middlesex Water Company

MSEX

Middlesex Water Company

HOLD

Current Price

$53.20

Market Cap

940.9M

Sector

Utilities

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.27

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSEX
IOVA
Founded
1897
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Water Supply
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
940.9M
968.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MSEX
IOVA
Price
$53.20
$2.27
Analyst Decision
Buy
Buy
Analyst Count
4
12
Target Price
$59.25
$10.36
AVG Volume (30 Days)
145.5K
9.8M
Earning Date
10-31-2025
11-06-2025
Dividend Yield
2.71%
N/A
EPS Growth
3.71
N/A
EPS
2.39
N/A
Revenue
$194,822,000.00
$250,425,000.00
Revenue This Year
$3.92
$60.94
Revenue Next Year
$8.51
$60.85
P/E Ratio
$22.24
N/A
Revenue Growth
6.24
175.62
52 Week Low
$44.17
$1.64
52 Week High
$67.09
$8.56

Technical Indicators

Market Signals
Indicator
MSEX
IOVA
Relative Strength Index (RSI) 55.99 49.91
Support Level $51.55 $2.18
Resistance Level $53.77 $2.32
Average True Range (ATR) 1.57 0.12
MACD 0.46 -0.01
Stochastic Oscillator 87.22 42.86

Price Performance

Historical Comparison
MSEX
IOVA

About MSEX Middlesex Water Company

Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The firm operates in the eastern states of New Jersey, Delaware, and Pennsylvania. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: